Product Information
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.0562 per ML under NDC 71656002216. Its NADAC has been published 83 times since Nov 27, 2024.
Strength
3 g/15mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656002216
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211648On Market Since
10/5/2023
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 83 times since Nov 27, 2024, and over the history we have for it it has risen 2.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per ML |
|---|---|
| All-time high | $0.0677 (Sep 10, 2025) |
| All-time low | $0.0440 (Dec 17, 2025) |
| 52-week high | $0.0677 |
| 52-week low | $0.0440 |
| Median price | $0.0502 |
| Average price | $0.0530 |
| Largest weekly change | +25.6% (Jun 17, 2026) |
| Weeks tracked | 83 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the POTASSIUM CHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Saptalis Pharmaceuticals LLC, is $0.0562 per ML (NDC 71656002216), effective Jun 24, 2026.
How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has risen 2.8%. It has been tracked across 83 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Since Nov 27, 2024, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.0677 (Sep 10, 2025), with a median of $0.0502 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 71656002216) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification